ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
UCB SA

UCB SA (UCB)

188.20
-1.15
(-0.61%)
終了 2月1日 1:30AM

個人投資家向けのプロ仕様のツール。

主要統計と詳細

通貨
188.20
買値
187.00
売値
188.60
出来高
299,025
186.90 日の範囲 191.30
85.76 52 週間の範囲 198.95
時価総額
前日終値
189.35
始値
189.35
最終取引時間
財務取引量
-
VWAP
-
平均取引量 (3 か月)
213,803
発行済株式数
194,506,000
配当利回り
-
PER
106.73
1 株当たり利益 (EPS)
1.76
歳入
4.87B
純利益
343M

UCB SA について

セクター
Pharmaceutical Preparations
業界
Chemicals & Allied Products
ウェブサイト
本社
Brussels, Brussels-capital Region, Bel
設立
1928
UCB SA is listed in the Pharmaceutical Preparations sector of the ユーロネクスト with ticker UCB. The last closing price for UCB was 189.35 €. Over the last year, UCB shares have traded in a share price range of 85.76 € to 198.95 €.

UCB currently has 194,506,000 shares in issue. The market capitalisation of UCB is 36.83 € billion. UCB has a price to earnings ratio (PE ratio) of 106.73.

UCB 最新ニュース

Dapirolizumab Pegol Phase 3 Data Presented at the American College of Rheumatology Shows Significant Reduction in Systemic Lupus Erythematosus Disease Activity

Dapirolizumab pegol (DZP) met its primary endpoint, demonstrating statistically and clinically significant improvement across all organ systems as measured by BICLA, an endpoint measuring disease...

UCB and Biogen Announce Positive Topline Results From Phase 3 Study of Dapirolizumab Pegol in Systemic Lupus Erythematosus and are Initiating Second Phase 3 Study in 2024

Phase 3 PHOENYCS GO study met the primary endpoint demonstrating clinical improvement in moderate-to-severe systemic lupus erythematosus; Clinical improvements were observed among key secondary...

UCB Convening Notice to the General Meeting of the Shareholders 2024

UCB Convening Notice to the General Meeting of the Shareholders 2024 CONVENING NOTICE TO THE GENERAL MEETING OF SHAREHOLDERS The Board of Directors invites the shareholders for the ordinary...

ClearPoint Neuro and UCB Enter License Agreement for Gene Therapy Drug Delivery

SOLANA BEACH, Calif., May 24, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) a global therapy-enabling platform company providing navigation and delivery to the brain, today...

UCB Convocation à L’ Assemblée Générale des Actionnaires 2023

UCB Convocation à L’ Assemblée Générale des Actionnaires 2023 CONVOCATION A L’ASSEMBLEE GENERALE DES ACTIONNAIRES Le Conseil d’Administration invite les actionnaires à l’assemblée générale...

Praxis Precision Medicines and UCB Announce Epilepsy Research Collaboration

BOSTON, Dec. 13, 2022 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company, and UCB (EURONEXT BRUSSELS: UCB), a global...

UCB SA - CONVOCATION A L’ASSEMBLEE GENERALE DES ACTIONNAIRES 2022

UCB SA - CONVOCATION A L’ASSEMBLEE GENERALE DES ACTIONNAIRES 2022 UCB -Société AnonymeAllée de la Recherche 60, 1070 Bruxellesn° d’entreprise 0403.053.608 (RPM Bruxelles)www.ucb.com(« UCB...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
14.82.61723009815183.4193.95181.85203170188.62254885DE
4-3.15-1.64619806637191.35198.95181.15198640188.69810699DE
125.152.81343895111183.05198.95163.4213803183.69942993DE
2629.818.8131313131158.4198.95141.65205144173.06699565DE
52100.7115.08571428687.5198.9585.76247343142.15517035DE
15699.2111.46067415789198.9565.4269520100.09184225DE
260105.78128.34263528382.42198.9560.1828968495.76552772DE

UCB - Frequently Asked Questions (FAQ)

What is the current UCB share price?
The current share price of UCB is 188.20 €
How many UCB shares are in issue?
UCB has 194,506,000 shares in issue
What is the market cap of UCB?
The market capitalisation of UCB is EUR 36.83B
What is the 1 year trading range for UCB share price?
UCB has traded in the range of 85.76 € to 198.95 € during the past year
What is the PE ratio of UCB?
The price to earnings ratio of UCB is 106.73
What is the cash to sales ratio of UCB?
The cash to sales ratio of UCB is 7.52
What is the reporting currency for UCB?
UCB reports financial results in EUR
What is the latest annual turnover for UCB?
The latest annual turnover of UCB is EUR 4.87B
What is the latest annual profit for UCB?
The latest annual profit of UCB is EUR 343M
What is the registered address of UCB?
The registered address for UCB is 60, ALLEE DE LA RECHERCHE, BRUSSELS, BRUSSELS-CAPITAL REGION, B-1070
What is the UCB website address?
The website address for UCB is www.ucb.com
Which industry sector does UCB operate in?
UCB operates in the CHEMICALS & ALLIED PRODUCTS sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
ALCYBCybergun
0.0002 €
(100.00%)
63.2M
TUVDSBio UV Group DS
0.015 €
(70.45%)
490.92k
CANDCandela Invest
1.70 €
(70.00%)
42
BIODSBiosynex DS
0.07 €
(39.44%)
55.52k
ALGTRGroupe Tera SA
4.10 €
(25.77%)
17.71k
MLIMLImalliance
0.282 €
(-27.32%)
1.5k
ALCARCarmat
0.822 €
(-22.60%)
3.04M
MLOCTOctopus Biosafety
0.14 €
(-21.35%)
18.55k
ALEXPOne Experience
0.386 €
(-21.22%)
933
SNGSonagi
0.80 €
(-20.00%)
800
ATOAtos SE
0.0023 €
(4.55%)
608.11M
ALVERVergnet
0.0011 €
(0.00%)
92.88M
ALCYBCybergun
0.0002 €
(100.00%)
63.2M
BCPBanco Comercial Portugues SA
0.5054 €
(0.04%)
32.95M
KPNKoninklijke KPN NV
3.491 €
(-1.77%)
16.54M

最近閲覧した銘柄

Delayed Upgrade Clock